Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection
In this cohort study of patients with stage II to IV colorectal cancer who underwent curative-intent resection, the addition of serial tumor-informed ctDNA assay to the standard NCCN-recommended surveillance had limited clinical benefits. Additional prospective research is needed to clarify the value of ctDNA testing in the surveillance setting.
Authors
- Jingran Ji (ORCID: https://orcid.org/0000-0002-7284-0709)
- Yuman Fong (ORCID: https://orcid.org/0000-0002-8934-9959)
- Lily Lai (ORCID: https://orcid.org/0000-0001-6639-4485)
- Laleh Golkar Melstrom (ORCID: https://orcid.org/0000-0001-6279-7981)
- Kurt Melstrom (ORCID: https://orcid.org/0000-0001-8085-998X)
- Marwan Fakih (ORCID: https://orcid.org/0000-0002-6554-5488)
- Chongkai Wang (ORCID: https://orcid.org/0000-0002-2186-8875)
- Mustafa Raoof (ORCID: https://orcid.org/0000-0003-4710-2226)
- Ajay Goel (ORCID: https://orcid.org/0000-0003-1396-6341)
- Andreas M. Kaiser (ORCID: https://orcid.org/0000-0003-4343-5189)
- Yasmin Zerhouni
Institutions
- City of Hope (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.52661
- Citations
- 5
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.43